The Use of Person-Centered Language in Scientific Research Articles Focused on Psychosis

在以精神病为主题的科学研究文章中使用以人为中心的语言

阅读:1

Abstract

PURPOSE: Societal stigma of psychosis leads to delayed treatment for individuals experiencing early symptoms, for fear of being labeled "crazy" or "psychotic." Delayed treatment can worsen the prognosis of individuals with psychosis. Proper adherence to person-centered language (PCL) guidelines can curb the widely held stigmatized preconceptions about psychotic conditions. METHODS: Our meta-epidemiological analysis began with a systematic search of literature in PubMed discussing psychosis from 2020-2022. From the 14,522 results, we randomly selected 500 articles in journals with at least 20 articles on psychosis (n=9,775), of which 241 articles met the inclusion criteria. These papers were screened for the usage of stigmatized language; article characteristics were also noted for further analysis. RESULTS: Our analysis revealed that 53.1% of articles screened included stigmatized language. The most common stigmatized phrase identified was "schizophrenia patient," found in 35.3% of papers. "Schizophrenic [patient/subject/etc]" and "psychosis patient" were each found in 12.4% of papers. The type of intervention (ie, pharmacologic, therapeutic, or observational) was the only variable that was found to be significant for PCL usage (P = 0.006). CONCLUSIONS: The majority of medical articles screened did not adhere to PCL guidelines. The usage of stigmatized language in literature reinforces the use of these labels in medical education, doctor's offices, and popular culture. Given the impact of stigma on treatment delay - and the poor prognosis that may result - proper care should be taken to enforce PCL in medical literature. Reducing the fear of labeling is a necessary step in encouraging treatment for people experiencing early symptoms of psychosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。